AVITA Medical, Inc.RCELNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
17.90%
↑ 281% above average
Average (39q)
-9.87%
Historical baseline
Range
High:57.54%
Low:-112.97%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 17.90% |
| Q2 2025 | 5.74% |
| Q1 2025 | -18.78% |
| Q4 2024 | 27.88% |
| Q3 2024 | 11.64% |
| Q2 2024 | 9.19% |
| Q1 2024 | -40.19% |
| Q4 2023 | -31.88% |
| Q3 2023 | 16.65% |
| Q2 2023 | -12.65% |
| Q1 2023 | -67.76% |
| Q4 2022 | -2.78% |
| Q3 2022 | 9.65% |
| Q2 2022 | 32.94% |
| Q1 2022 | -11.95% |
| Q4 2021 | -42.44% |
| Q3 2021 | -26.47% |
| Q2 2021 | 21.48% |
| Q1 2021 | -6.39% |
| Q4 2020 | 44.87% |
| Q3 2020 | 21.57% |
| Q2 2020 | 15.47% |
| Q1 2020 | -45.45% |
| Q4 2019 | -95.44% |
| Q3 2019 | 57.54% |
| Q2 2019 | 0.00% |
| Q1 2019 | -75.27% |
| Q4 2018 | 2.54% |
| Q3 2018 | 46.01% |
| Q2 2018 | -112.97% |
| Q1 2018 | -49.64% |
| Q4 2017 | 0.50% |
| Q3 2017 | 3.88% |
| Q2 2017 | -0.60% |
| Q1 2017 | -62.89% |
| Q4 2016 | 5.73% |
| Q3 2016 | 0.23% |
| Q2 2016 | 3.07% |
| Q1 2016 | -42.02% |
| Q4 2015 | -3.59% |